Lupin Ltd

Overview

Lupin Ltd (Lupin) develops and manufactures generic and branded formulations, biotechnology products and active pharmaceutical ingredients (APIs). It has expertise in the areas of cardiovascular, asthma, diabetology, pediatrics, central nervous system, gastro-intestinal, anti-infectives, nonsteroidal anti-inflammatory drugs (NSAIDs), anti-TB and cephalosporins. The company undertakes extensive research and development of pharmaceuticals for treatment of migraine, gastrointestinal, psoriasis, central nervous system, cardiovascular, tuberculosis, diabetes and inflammation. Lupin develops value-added generic pharmaceuticals based on its platform technologies. The company along with its subsidiaries has manufacturing facilities in India, the US, Mexico and Brazil. Lupin is headquartered in Mumbai, Maharashtra, India.
Key Stats
Address
B/4 Laxmi Towers, , Bandra Kurla Complex, Bandra (E), Santacruz East, MUMBAI, India
Headquarters

India

Contact

91 22 66402222

Website
www.lupin.com
No of Employees

18,573

Industry

Pharmaceuticals and Healthcare

Ticker Symbol & Exchange​

LUPIN [NSE]

Revenue (2021)

$2,052 m

-1.4% (2021 vs 2020)
Net Income (2021)

$165 m

552.6% (2021 vs 2020)
Net Profit Margin

8 %

558.3% (2021 vs 2020)
Market Cap *

$6,102 m

EPS *

$0.4

  *Note: Ratios based on the share price as of 8-September-2021, in absolute numbers and US$.

Peer Comparison

Key Parameters Lupin LtdSun Pharmaceutical Industries LtdCipla LtdDr. Reddy's Laboratories Ltd
Key Information
Headquarters India India India India
Headquarter City MUMBAI MUMBAI MUMBAI HYDERABAD
Headquarter State/Province - - - -
No. of Employees 18,573 37,000 21,565 22,739
Entity Type Public Public Public Public

Products & Services

Lupin is an innovation led transnational pharmaceutical company that develops and delivers a range of branded and generic formulations, biotechnology products and APIs globally. Based on therapy area the company’s key products and brands include the following:

Products
  • Anti-Tuberculosis: Tablets and Capsules
  • Diabetes Management: Tablets, Injections, Capsules, Insulin Cartridge and Devices
  • Cardiac Care: Tablets, Injections, Capsules and Injectables
  • Vitae Eget Libero
  • Vitae Eget Libero
  • Vitae Eget Libero
  • Vitae Eget Libero
  • Vitae Eget Libero
  • Vitae Eget Libero
  • Vitae Eget Libero
Services
  • Contract Manufacturing:
  • API Biologics (Protein and Peptide)
  • API Chemical
  • Etiam Rutrum Elit
  • Etiam Rutrum Elit
  • Etiam Rutrum Elit
  • Etiam Rutrum Elit
  • Etiam Rutrum Elit
Brands
  • Rcinex
  • Akurit
  • AKT
  • Rutrum Elit
  • Rutrum Elit
  • Rutrum Elit
  • Rutrum Elit
  • Rutrum Elit
  • Rutrum Elit
  • Rutrum Elit
Key Financial Charts
Sales Growth
Operating Margin
Net Income Growth
EPS (Earnings per Share)
Debt to Equity Ratio
Return on Assets

Employees

Name Position Board Since Age Biography
J. Alan Butcher Chief Corporate Development Officer Senior Management 2020 - Mr. J. Alan Butcher has been the Chief Corporate Development Officer of the company since January 2020. Previously, he served...
Ramesh Swaminathan Chief Financial Officer; Director; Head of Corporate Affairs Executive Board 2020 - Mr. Ramesh Swaminathan is the Chief Financial Officer, Executive Director, and Head Corporate Affairs at Lupin.
Sreeji Gopinathan Chief Information Officer Senior Management 2019 - Mr.Sreeji Gopinathan has been the Chief Information Officer of the company since 2019. Prior to this, Sreeji was with Reckitt...
Non Dignissim Eros Proin vel Convallis 2015 XX In vitae nisi ut tortor rutrum suscipit vel vitae ligula. Mauris sed tellus non augue ultricies ultricies. Aliquam vitae urna congue.
Non Dignissim Eros Proin vel Convallis 2015 XX In vitae nisi ut tortor rutrum suscipit vel vitae ligula. Mauris sed tellus non augue ultricies ultricies. Aliquam vitae urna congue.

History

Year Event Description
2021 Contracts/Agreements In February, the company's subsidiary, Lupin Pharmaceuticals and Phil, Inc., entered into a partnership to…
2021 New Products/Services In February, the company announced the launch of the Posaconazole Delayed-Release Tablets.
2021 Others In April, the company launched a subsidiary, Lupin Oncology Inc, in the US.
2021 Quis autem vel Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam
2021 Quis autem vel Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam
2021 Quis autem vel Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam

Locations


Lupin Pharmaceuticals Inc

Address

21st Floor, Harborplace Tower, 111 S Calvert Street, Baltimore
United States of America

Telephone

1 410 5762000

Website

www.lupin.com/US/
Temmler Pharma GmbH & Co KG

Address

Temmlerstrasse 2, Marburg
Germany

Telephone

49 64 214940

Website

www.temmler.eu
Pharma Dynamics Pty Ltd

Address

1st Floor, Grapevine House,, Silverwood Close, Steenberg Office Park, Westlake, Cape Town
South Africa

Telephone

27 860 742762

Website

www.pharmadynamics.co.za
Novodigm Limited

Address

Block 21, Dabhasa, Padra Taluka, Vadodara
India

Telephone

1 2662 306306

Laboratorios Grin SA de CV

Address

Rodriguez Saro No. 630, Mexico City
Mexico

Telephone

52 55 52002300

Website

www.laboratoriosgrin.com
Multicare Pharmaceuticals Philippines Inc

Address

26th Floor, Rufino Tower, 6784 Ayala Avenue, Makati
Philippines

Telephone

63 2 8110636

Website

www.multicare.com.ph
Nanomi BV

Address

Zutphenstraat 51, Oldenzaal
Netherlands

Telephone

31 8 80040800

Website

www.nanomi.com
Hormosan Pharma GmbH

Address

Wilhelmshoher Str. 106, Frankfurt
Germany

Telephone

49 69 478730

Website

www.hormosan.com

Deals

Number of Deals
Deal Value (US$ m)

Latest Deals

Announced Date Headline Deal Type Acquirers / Investors / Surviving Entity Issuer / partner / Target
06 Sep 2021 Lupin Enters into License Agreement with TB Alliance Licensing Agreement Lupin Ltd TB Alliance
10 May 2021 Lupin Enters into Licensing Agreement with Eli Lilly for COVID-19 Treatment Licensing Agreement Lupin Ltd Eli Lilly and Co
31 Mar 2021 Consortium Investors May Acquire Pharmarack Technologies Acquisition Sun Pharmaceutical Industries Ltd; Lupin Ltd; Cadila Healthcare Ltd Pharmarack Technologies Private Limited
03 Jun 2020 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit
03 Jun 2020 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit
03 Jun 2020 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit

Jobs Overview

3

Active Jobs

3

Posted

2

Closed

Job Trends

Latest Jobs

Job title Company Country
Officer / Junior Officer - Production Lupin Ltd India
Officer - Quality Control Lupin Ltd India
Cras Malesuada Dolor nisi Lorem minim amet cillum elit. Cursus Sed Pulvinar
Cras Malesuada Dolor nisi Lorem minim amet cillum elit. Cursus Sed Pulvinar
Cras Malesuada Dolor nisi Lorem minim amet cillum elit. Cursus Sed Pulvinar
Cras Malesuada Dolor nisi Lorem minim amet cillum elit. Cursus Sed Pulvinar